Merit Common Stock Total Equity from 2010 to 2024

MMSI Stock  USD 95.50  0.98  1.02%   
Merit Medical's Common Stock Total Equity is increasing with slightly volatile movements from year to year. Common Stock Total Equity is estimated to finish at about 815.3 M this year. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
1999-06-30
Previous Quarter
681.1 M
Current Value
691.5 M
Quarterly Volatility
236.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 106.4 M, Interest Expense of 19 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 2.66, Dividend Yield of 0.0 or PTB Ratio of 3.6. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Check out the analysis of Merit Medical Correlation against competitors.

Latest Merit Medical's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Merit Medical Systems over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Merit Medical's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Merit Common Stock Total Equity Regression Statistics

Arithmetic Mean410,194,247
Geometric Mean299,701,591
Coefficient Of Variation64.52
Mean Deviation240,225,863
Median353,392,000
Standard Deviation264,669,466
Sample Variance70049.9T
Range796.9M
R-Value0.97
Mean Square Error5040.6T
R-Squared0.93
Slope57,170,514
Total Sum of Squares980699T

Merit Common Stock Total Equity History

2024815.3 M
2023776.5 M
2022675.2 M
2021641.5 M
2020606.2 M
2019587 M
2018571.4 M

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Common Stock Total Equity776.5 M815.3 M

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out the analysis of Merit Medical Correlation against competitors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.743
Earnings Share
2.01
Revenue Per Share
22.476
Quarterly Revenue Growth
0.056
Return On Assets
0.0448
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.